Form D · Biotechnology

Neon Therapeutics, Inc.

Cambridge, MA · CIK 0001694187

Offering snapshot reported Dec 13, 2017 · SEC filing

Reported sold
$106M
Offering amount: $106M
Investors reported
25
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 28, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$53M$106MJan 11, 2017: $69,999,995.00Jan 11, 2017Dec 13, 2017: $105,999,996.00Dec 13, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$69,999,995 → $105,999,996
  • Reported investors14 → 25

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 13, 2017Amendment$105,999,996$36,000,001vs Jan 11, 201725SEC filing
Jan 11, 2017Initial$69,999,995No comparison14SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-278190

Source: Form D, filed Dec 13, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Yasir Al Wakeel Executive
Robert Ang, M.D. Executive
Daniella Beckman Executive
Hugh Dowd Director, Executive
Richard Gaynor, M.D. Executive
Robert Kamen Director
Eric Lander Director
Cary Pfeffer, M.D. Director
Stephen Sherwin Director
Robert Tepper Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
40 Erie Street Suite 110
Cambridge, MA, 02139